Advertisement
UK markets closed
  • NIKKEI 225

    41,275.08
    +84.40 (+0.20%)
     
  • HANG SENG

    17,727.98
    -287.96 (-1.60%)
     
  • CRUDE OIL

    80.88
    -1.03 (-1.26%)
     
  • GOLD FUTURES

    2,473.10
    +44.20 (+1.82%)
     
  • DOW

    40,954.48
    +742.76 (+1.85%)
     
  • Bitcoin GBP

    49,970.33
    +821.58 (+1.67%)
     
  • CMC Crypto 200

    1,348.00
    +7.04 (+0.52%)
     
  • NASDAQ Composite

    18,509.34
    +36.77 (+0.20%)
     
  • UK FTSE All Share

    4,482.44
    -7.75 (-0.17%)
     

Nanox to Report First Quarter and Financial Results on May 28, 2024

Nano-X Imaging LTD.
Nano-X Imaging LTD.

PETACH TIKVA, Israel, May 20, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31, 2024, before market open on Tuesday, May 28, 2024. Erez Meltzer, Chief Executive Officer, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.

Interested parties may register for the conference call using the following link:  Nanox Q1 Earnings Call Registration. You may access the live webcast of the conference call by using the following link: Nanox Q1 Earnings Webcast. The link will also be posted in the Investor Relations section of the Nanox website at Events and Presentations.

About Nanox

Nanox (NASDAQ: NNOX) is focused on applying its proprietary medical imaging technology and solutions to make diagnostic medicine more accessible and affordable across the globe. Nanox’s vision is to increase access, reduce costs and enhance the efficiency of routine medical imaging technology and processes, in order to improve early detection and treatment, which Nanox believes is key to helping people achieve better health outcomes, and, ultimately, to save lives. The Nanox ecosystem includes Nanox.ARC— a multi-source Digital Tomosynthesis system that is cost-effective and user-friendly; an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic disease (Nanox.AI); a cloud-based infrastructure (Nanox.CLOUD); and a proprietary decentralized marketplace, through Nanox’s subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts; and a comprehensive teleradiology services platform (Nanox.MARKETPLACE). Together, Nanox’s products and services create a worldwide, innovative, and comprehensive solution that connects medical imaging solutions, from scan to diagnosis. For more information, please visit www.nanox.vision.

Contacts

Media Contact:
Ben Shannon
ICR Westwicke
NanoxPR@icrinc.com

Investor Contact:
Mike Cavanaugh
ICR Westwicke
mike.cavanaugh@westwicke.com